Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesVascular/Cardiothoracic Surgerypriority health Carotid Intracranial Stenting Cove…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Currentpriority healthPolicy 91495

    CAROTID AND INTRACRANIAL ARTERY STENTING

    Customize your policy alerts

    Sign up for priority health Policy 91495 alerts

    Get alerted when Policy 91495 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical necessity criteria for carotid and intracranial artery stenting procedures (including TCAR and TF‑CAS), transcatheter extracranial vertebral or intrathoracic carotid stents, and intracranial angioplasty/stenting for Priority Health members.

    Policy Summary
    Payerpriority health
    PolicyCAROTID AND INTRACRANIAL ARTERY STENTING
    Policy CodePolicy 91495
    Change TypeClarified: delegates to InterQual
    Effective DateAug 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateMay 13, 2026
    Key ActionUse applicable InterQual criteria to document and establish medical necessity for carotid and intracranial stenting requests.
    SourceLink
    POLICY UPDATE CHANGES

    Carotid artery stenting: Priority Health considers stenting of the carotid artery medically necessary when the applicable InterQual® criteria are met

    Intracranial angioplasty and stenting: Priority Health considers intracranial angioplasty and stenting medically necessary when the applicable InterQual® criteria are met

    InterQual referencedInterQual decision support
    TCAR & TF-CASApproaches included
    InvestigationalIntracranial vasospasm stance
    7Covered CPT/HCPCS
    InterQual®Decision support system

    Coverage and Medical Necessity Criteria

    Medical necessity criteria

    Covered when InterQual® procedure-specific criteria are met.

    Carotid artery stenting (extracranial): Carotid artery stenting is considered medically necessary when the applicable InterQual® 'Angioplasty and Stent, Carotid or Vertebral' criteria are met.InterQual criteria

    Includes Transfemoral CAS (TF-CAS) and Transcarotid Artery Revascularization (TCAR); transcatheter placement of extracranial vertebral or intrathoracic carotid artery stents is managed by TurningPoint Healthcare Solutions LLC (see Authorization pathway).

    Intracranial angioplasty and stenting are considered medically necessary when the applicable InterQual® 'Endovascular Intervention, Intracranial' criteria are met.InterQual criteria

    InterQual procedure-level criteria and evidence appraisal inform determination; guideline support may be limited and additional review may be required.

    Policy Summary
    Payerpriority health
    PolicyCAROTID AND INTRACRANIAL ARTERY STENTING
    Policy CodePolicy 91495
    Change TypeClarified: delegates to InterQual
    Effective DateAug 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateMay 13, 2026
    Key ActionUse applicable InterQual criteria to document and establish medical necessity for carotid and intracranial stenting requests.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaRegulatory, Device and Billing CodesAuthorization, Documentation and Denial Guidance for ProvidersClinical Background and Definitions
    Intracranial vasospasm balloon dilatation: Percutaneous balloon dilatation of intracranial vasospasm is considered investigational and experimental.N/A

    Not covered as standard therapy under this policy.

    Medically Necessary Criteria (delegated to InterQual)

    Covered when the applicable InterQual criteria are met for the specific procedure.

    Carotid artery stenting is considered medically necessary when the applicable InterQual criteria are met.InterQual criteria

    See InterQual for detailed, procedure‑specific clinical criteria to support medical necessity determinations.

    Intracranial angioplasty and stenting are considered medically necessary when the applicable InterQual criteria are met.InterQual criteria

    See InterQual for detailed, procedure‑specific clinical criteria to support medical necessity determinations.

    Priority Health considers percutaneous balloon dilatation of intracranial vasospasm to be investigational and experimental. This therapy is not established as standard treatment in the policy and is not covered as routine care.

    This regulatory excerpt lists FDA product and decision identifiers (K-numbers) for embolic protection devices and related systems. The section is informational and does not state coverage, exclusion, or medical-necessity determinations.

    The listing documents device names and associated FDA 510(k) identifiers (for example, MO.MA Ultra Proximal Cerebral Protection Device K092177, Guardwire K072990, FilterWire EZ K063313). No coverage or exclusion language is provided in this regulatory excerpt.

    This regulatory excerpt supplies device names, manufacturers, K-numbers and clearance dates for embolic protection devices and capture guidewires (examples include FilterWire EZ, ANGIOGUARD, and SPIDERFX). The excerpt contains only regulatory clearance information and does not specify coverage criteria.

    The section enumerates FDA 510(k) identifiers and clearance dates for embolic protection systems (for example, Emboshield NAV6 K191173 and ANGIOGUARD K220654). It is a regulatory device listing and does not include statements about medical necessity or coverage decisions.

    This excerpt continues device clearance listings (including ACCUNET K153086 and multiple K-numbers for Emboshield NAV6 and SPIDERFX). The content is informational regarding FDA clearances and does not provide coverage or exclusion determinations.

    The regulatory section lists additional K-numbers and named embolic protection systems (ACCUNET, Emboshield NAV6, and related clearances). No policy statements of 'not medically necessary' or explicit coverage guidance are included in this excerpt.

    This regulatory listing documents FDA K-number clearances and device names for embolic protection systems and related guidewires. The section is informational; it does not include statements declaring devices or procedures as not medically necessary.

    The following CPT codes for balloon dilatation of intracranial vasospasm are designated Not Medically Necessary in this policy: 61640, 61641, 61642.

    Procedures that do not meet the applicable InterQual® criteria for the requested intervention will not satisfy this policy's medical necessity requirements and may be denied. Providers should use InterQual criteria to document clinical indications when requesting coverage.

    The policy text explicitly labels percutaneous balloon dilatation of intracranial vasospasm as investigational/experimental, indicating it is not an established, covered therapy under this policy.

    This regulatory excerpt provides FDA device names and 510(k) identifiers (for example, MO.MA K092177, Guardwire K072990, FilterWire EZ K063313). It contains no statements declaring the listed devices or related procedures as not medically necessary.

    The excerpt lists device families and their FDA 510(k) identifiers (for example, Emboshield NAV6 and SPIDERFX) along with clearance dates. No not-medically-necessary determinations are made in this regulatory listing.

    This regulatory passage documents multiple K-number clearances for embolic protection systems (including ACCUNET and Emboshield NAV6). The excerpt is limited to clearance information and does not state coverage exclusions.

    The policy identifies specific CPT codes for intracranial vasospasm dilation—61640, 61641, 61642—and considers these codes not medically necessary for coverage.

    Any carotid or intracranial stenting procedure that does not meet the applicable InterQual® criteria is considered not medically necessary under this policy. Providers must document how the case meets InterQual criteria to support medical necessity.

    Regulatory, Device and Billing Codes

    FDA device decision / product codes citedmixed
    P240029CGuard™ Prime Carotid Stent PMA/decision number
    P240009Neuroguard IEP® 3-in-1 Carotid Stent decision number
    P180010ENROUTE Transcarotid Stent PMA/decision number
    P140026ENROUTE Transcarotid Stent System decision/PMA references
    P040038XACT Carotid Stent System PMA/decision number
    P040012ACCULINK Carotid Stent System PMA/decision number
    P030047CORDIS PRECISE Nitinol Stent System PMA/decision number
    K222694EmPro EPS / Nanoparasol EPS (NTE) product code
    K210282WIRION product code
    FDA K-numbers referencedmixed
    K120480listed for GORE FLOW REVERSAL / GORE EMBOLIC FILTER entries
    K103500listed for GORE FLOW REVERSAL / GORE EMBOLIC FILTER entries
    K123156listed for GORE FLOW REVERSAL / FIBERNET EMBOLIC PROTECTION DEVICE / MO.MA entries
    K083300listed for GORE and other embolic protection device entries
    K111987listed for FIBERNET / MO.MA and other device entries
    K082348listed for FIBERNET / MO.MA and related devices
    K092177listed for MO.MA Ultra Proximal Cerebral Protection Device / related entries
    K072990listed for GUARDWIRE TEMPORARY OCCLUSION AND ASPIRATION SYSTEM / CAROTID entries
    K063313listed for FilterWire EZ Embolic Protection System entries
    FDA 510(k)/K numbers - primary devicesmixed
    K092177MO.MA Ultra Proximal Cerebral Protection Device (Invatec S.p.A.)
    K072990GUARDWIRE TEMPORARY OCCLUSION AND ASPIRATION SYSTEM- CAROTID (Medtronic, Inc.)
    K063313FilterWire EZ Embolic Protection System (Boston Scientific)
    ANGIOGUARD related clearancesmixed
    K220654ANGIOGUARD XP / ANGIOGUARD RX (Cordis)
    K101651ANGIOGUARD RX / related clearance
    SPIDERFX/EV3 clearancesmixed
    K111010SPIDERFX EMBOLIC PROTECTION DEVICE (Ev3)
    K063204SPIDERFX / related clearance entries
    K052659Additional related K-number listed with SPIDERFX entries
    Emboshield and additional clearancesmixed
    K191173Emboshield NAV6 Embolic Protection (clearance referenced)
    K141678Additional clearance number referenced in list
    FDA 510(k) / K-number listings for embolic protection devices and guidewiresmixed
    K063313FilterWire EZ Embolic Protection System (3.5-5.5 mm) (Boston Scientific) (NTE)
    K220654ANGIOGUARD XP / ANGIOGUARD RX Emboli Capture Guidewire (Cordis)
    K101651ANGIOGUARD XP / ANGIOGUARD RX Emboli Capture Guidewire (Cordis)
    K062531ANGIOGUARD XP / ANGIOGUARD RX Emboli Capture Guidewire (Cordis) (NTE)
    K111010SPIDERFX EMBOLIC PROTECTION DEVICE (Ev3, Inc.)
    K063204SPIDERFX EMBOLIC PROTECTION DEVICE (Ev3, Inc.)
    K052659SPIDERFX EMBOLIC PROTECTION DEVICE (Ev3, Inc.) (NTE)
    K191173Emboshield NAV6 Embolic Protection System (incl. BareWire filter delivery wire) (Abbott Laboratories)
    K141678Emboshield NAV6 Embolic Protection System (Abbott Laboratories)
    K121015Emboshield NAV6 related clearance (Abbott Laboratories)
    1–10 of 14
    1/2
    FDA 510(k) / K-numbers and device identifiersmixed
    K220654FDA 510(k) identifier associated with ANGIOGUARD XP / ANGIOGUARD RX (Cordis)
    K101651FDA 510(k) identifier listed for AngioGuard/guidewire entries
    K062531FDA 510(k) identifier (NTE) listed with Cordis guidewire entries
    K111010FDA 510(k) identifier for SPIDERFX EMBOLIC PROTECTION DEVICE (Ev3, Inc.)
    K063204FDA 510(k) identifier for SPIDERFX
    K052659FDA 510(k) identifier for SPIDERFX
    K191173FDA 510(k) identifier for Emboshield NAV6 Embolic Protection System (Abbott Laboratories)
    K141678FDA 510(k) identifier for Emboshield NAV6
    K121015FDA 510(k) identifier for Emboshield NAV6
    K110909FDA 510(k) identifier for Emboshield NAV6
    1–10 of 15
    1/2
    FDA K-number device listingsmixed
    K191173Emboshield NAV6 Embolic Protection System (incl. BareWire filter delivery wire) (Abbott Laboratories)
    K141678Ancillary K-number listed with Emboshield NAV6
    K121015Ancillary K-number listed with Emboshield NAV6
    K110909Ancillary K-number listed with Emboshield NAV6
    K090665Ancillary K-number listed with Emboshield NAV6
    K081523Ancillary K-number listed with Emboshield NAV6
    K052454Ancillary K-number listed with Emboshield NAV6
    K153086ACCUNET Embolic Protection System / RX ACCUNET
    K081549ACCUNET related K-number
    K111010SPIDERFX EMBOLIC PROTECTION DEVICE (Ev3, Inc.)
    1–10 of 17
    1/2
    FDA K-number clearances and named devicesmixed
    K110909FDA K-number listed for ACCUNET/embolic protection devices
    K090665FDA K-number listed for ACCUNET/embolic protection devices
    K081523FDA K-number listed for ACCUNET/embolic protection devices
    K052454FDA K-number listed for ACCUNET/embolic protection devices
    K153086FDA K-number listed for ACCUNET Embolic Protection System / RX ACCUNET
    K081549FDA K-number listed for ACCUNET Embolic Protection System
    K052165FDA K-number listed for ACCUNET Embolic Protection System
    K042908FDA K-number listed for ACCUNET Embolic Protection System
    K063204FDA K-number listed for PROTECTION DEVICE (Ev3, Inc.)
    K052659FDA K-number listed for PROTECTION DEVICE (Ev3, Inc.)
    1–10 of 13
    1/2
    Covered CPT CodesCPTCovered
    37215Transcatheter placement of intravascular stent(s), cervical carotid artery; with distal embolic protection
    37216Transcatheter placement of intravascular stent(s), cervical carotid artery; without distal embolic protection
    37217Transcatheter placement of intravascular stent(s), intrathoracic common carotid artery or innominate artery by retrograde treatment
    37218Transcatheter placement of intravascular stent(s), intrathoracic common carotid artery or innominate artery, open or percutaneous antegrade approach
    61630Balloon angioplasty, intracranial (e.g., atherosclerotic stenosis), percutaneous
    61635Transcatheter placement of intravascular stent(s), intracranial, including balloon angioplasty if performed
    Category III / HCPCS 'T' codesHCPCS
    0075TTranscatheter placement of extracranial vertebral artery stent(s); initial vessel
    0076TTranscatheter placement of extracranial vertebral artery stent(s); each additional vessel
    Not Medically Necessary CodesCPTNot Covered
    61640Balloon dilatation of intracranial vasospasm, percutaneous; initial vessel
    61641Balloon dilatation of intracranial vasospasm, percutaneous; each additional vessel in same vascular family
    61642Balloon dilatation of intracranial vasospasm, percutaneous; each additional vessel in different vascular family
    ICD-10 Codes that may support medical necessityICD-10
    I63.031 - I63.039Cerebral infarction due to thrombosis of carotid artery (range)
    I63.131 - I63.139Cerebral infarction due to embolism of carotid artery (range)
    I63.231 - I63.239Cerebral infarction due to unspecified occlusion or stenosis of carotid arteries (range)
    I65.21 - I65.29Occlusion and stenosis of carotid artery (range)
    I65.8Occlusion and stenosis of other precerebral arteries

    Authorization, Documentation and Denial Guidance for Providers

    Prior Authorization

    Authorization pathway — TurningPoint lookup

    Transcatheter placement of extracranial vertebral or intrathoracic carotid artery stents is managed by TurningPoint Healthcare Solutions LLC; use Priority Health Prism → Authorizations → Authorization Criteria Lookup to access TurningPoint and determine authorization requirements.

    • Authorization pathway for extracranial vertebral/intrathoracic stents managed by TurningPoint via Priority Health Prism.
    Prior Authorization

    Prior authorization — none indicated in device listings

    This regulatory listing and device clearance sections do not specify a standing prior‑authorization rule for the devices listed; when prior authorization is required it will be identified via Priority Health Prism or plan‑specific documentation.

    • No explicit prior authorization requirement stated in the FDA device/K‑number listings.
    Prior Authorization

    Prior authorization not specified in this excerpt

    The device regulatory excerpts list FDA 510(k)/K‑number clearances but do not state a provider prior‑authorization workflow; check Priority Health Prism for any procedure‑ or plan‑specific authorization requirements.

    • Regulatory device listings include K092177, K072990, K063313 and others but do not define prior authorization.
    Prior Authorization

    Prior authorization — none specified (device listings)

    The regulatory device section enumerates multiple FDA K‑numbers and device names without a stated prior authorization requirement; treat these listings as informational and follow Prism for authorization rules.

    • FDA K‑numbers and device names listed are informational; authorization status must be verified in Priority Health systems.
    Note

    FDA device clearances — informational only

    FDA device clearances are presented for informational purposes in the regulatory listing; the document does not establish prior authorization mandates for the named devices.

    • Clearance entries (e.g., Emboshield NAV6 K191173, ACCUNET K153086) are informational and not an authorization instruction.
    Documentation Required

    Document device-specific FDA 510(k) K‑numbers

    The document lists specific FDA 510(k)/K‑numbers (examples include K191173, K141678, K121015, K110909, K090665, K081523, K052454, K153086, K111010, K063204, K052659, K062531, K101651, K052165, K042908, K042218) that should be cited in device identification and claims when relevant.

    • Cite the exact FDA K‑number(s) associated with the embolic protection device used (examples shown above).
    • Device K‑numbers are listed across the regulatory section and should be included in documentation when relevant to coding or review.
    Prior Authorization

    Prior authorization — none specified for embolic protection systems

    The regulatory listings for embolic protection systems do not include a standing prior authorization requirement; they provide device clearances and identifiers only.

    • Emboshield NAV6, ACCUNET, SPIDERFX and related K‑numbers are listed without authorization instructions.
    Prior Authorization

    Determine prior authorization via Priority Health Prism

    Prior authorization may be required for certain procedures or devices; providers should use Priority Health Prism Authorization Criteria Lookup to access InterQual or TurningPoint guidance and submit medical‑necessity documentation when required.

    • Use Priority Health Prism → Authorizations → Authorization Criteria Lookup to determine if prior authorization is required.
    • When required, submit documentation demonstrating medical necessity per InterQual or TurningPoint criteria.
    Documentation Required

    Use and document InterQual criteria for medical necessity

    Medical necessity and prior authorization determinations for carotid and intracranial procedures are governed by the applicable InterQual clinical criteria referenced in this policy; document which InterQual criteria were applied.

    • Use the InterQual ‘Angioplasty and Stent, Carotid or Vertebral’ and ‘Endovascular Intervention, Intracranial’ criteria as applicable.
    • Record the specific InterQual criteria and results used to support medical necessity in the authorization or claim documentation.
    Documentation Required

    Document baseline medical management prior to invasive therapy

    Standard medical management (antiplatelet therapy, blood pressure and lipid control, and lifestyle measures) is described as the baseline approach when clinically appropriate prior to invasive revascularization.

    • Ensure conservative/medical therapy has been considered and documented where clinically appropriate prior to stenting.
    • Document antiplatelet regimen, BP and lipid control efforts, and lifestyle counseling when relevant to medical‑necessity review.
    Step Therapy

    Step therapy — none specified

    No step‑therapy requirements are specified in the policy text or regulatory device listings.

    • The policy and device sections do not impose step‑therapy rules; follow InterQual and plan benefit requirements instead.
    Documentation Required

    Confirm member benefits and CMS guidance in documentation

    Follow member benefit terms and applicable CMS NCD/LCD guidance; document that the patient’s coverage permits the requested service because group‑specific plan documents may supersede this policy.

    • Confirm member benefits and plan‑specific provisions before requesting authorization.
    • Include references to applicable CMS NCD/LCDs when relevant to Medicare members (e.g., PTA NCD 20.7).
    Documentation Required

    Document device identification and FDA K‑number on records/claims

    Regulatory device listings should be recorded in clinical and coding records when relevant: document the specific device used and the corresponding FDA K‑number on claims and in the medical record.

    • When an embolic protection device is used, record the device name and its FDA K‑number (examples: Emboshield NAV6 K191173; ACCUNET K153086).
    • Include device identification in operative notes and billing records if device‑specific review or coding depends on it.
    Prior Authorization

    Submit medical‑necessity request and seek prior plan approval for investigational care

    When prior authorization is required, submit a request demonstrating medical necessity; individual case review may allow coverage for investigational treatments only with prior plan approval and review by a Priority Health medical director or clinical pharmacist.

    • Requests for investigational or unproven treatments require prior plan approval and review by Priority Health clinical leadership.
    • Provide complete medical rationale and InterQual or TurningPoint documentation when seeking individual consideration.
    Denial Risk

    Denial risk — investigational/individual review required

    Requests for experimental, investigational, or unproven treatments will be denied unless prior plan approval via individual case review is obtained; all such determinations are made by a Priority Health medical director or clinical pharmacist.

    • Do not bill or assume coverage for investigational procedures without prior plan approval.
    • Individual case review is required for exceptions to investigational exclusions.
    Denial Risk

    Denial risk — non‑adherence to InterQual criteria

    If the applicable InterQual criteria are not met, the procedure would not satisfy this policy's medical necessity condition and may be denied.

    • Document which InterQual criteria were evaluated and include supporting clinical data to avoid denials tied to InterQual adjudication.
    • Procedures failing InterQual criteria are at risk for denial.
    Documentation Required

    Device listings are informational — no documentation mandates stated

    No provider‑level authorization or documentation requirements are specified within the raw FDA device/K‑number listings; those chunks are informational device clearances only.

    • Device listings (FDA K‑numbers and dates) do not prescribe documentation workflows; follow policy sections on authorization and documentation for requirements.
    Denial Risk

    Denial risk — intracranial vasospasm balloon dilatation is investigational (CPT 61640‑61642)

    The regulatory excerpts reiterate that percutaneous balloon dilatation of intracranial vasospasm is considered investigational/experimental and listed CPT codes 61640–61642 are identified as not medically necessary.

    • Do not submit claims expecting coverage for CPT 61640, 61641, 61642 without prior plan approval; these are listed as not medically necessary.
    • If pursuing individual consideration, obtain prior plan approval and document clinical justification.
    Documentation Required

    Document the specific InterQual/TurningPoint criteria used in authorization requests

    When using Priority Health Prism for authorizations, document the specific InterQual or TurningPoint guideline page or criteria used to support the request.

    • Include the InterQual criteria name (e.g., 'Angioplasty and Stent, Carotid or Vertebral' or 'Endovascular Intervention, Intracranial') in authorization submissions.
    • Attach the InterQual decision output or relevant clinical fields to the prior‑authorization request.
    Documentation Required

    Verify eligibility and plan benefit limitations

    Benefit limitations and group‑specific plan documents may override this policy; confirm eligibility and benefit coverage before performing or billing for the procedure.

    • Verify coverage via benefits and eligibility prior to scheduling procedures.
    • Include plan‑specific references in the authorization or claim when relevant.
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note
    Note

    Clinical Background and Definitions

    Background: The carotid arteries supply blood to the brain, and significant atherosclerotic stenosis increases ischemic stroke risk. Diagnostic options include duplex ultrasound, CT angiography, digital subtraction angiography, and MR angiography. Management begins with standard medical therapy (antiplatelet agents, blood pressure and lipid control, and lifestyle measures); for selected patients with severe symptomatic disease, revascularization via carotid endarterectomy or carotid stenting (transfemoral or transcarotid approaches) may be appropriate. InterQual® procedural criteria are used by Priority Health to determine medical necessity for carotid and intracranial endovascular interventions.

    Carotid artery stenting (CAS) — definition & intent
    DefinitionEndovascular treatment involving balloon dilatation of a stenotic carotid lesion followed by stent placement to restore vascular patency and reduce embolization risk.
    Clinical intentImprove cerebral blood flow, reduce risk of embolization to the brain, and prevent stroke or recurrent stenosis.
    Included approachesTranscarotid Artery Revascularization (TCAR) and Transfemoral Carotid Artery Stenting (TF-CAS) are explicitly included.
    TCAR vs TF-CAS — differences and indications
    TCAR (transcarotid)Direct transcarotid access; may be preferred for tortuous aortic arch, documented aortoiliac occlusive disease, or prior neck surgery.
    TF-CAS (transfemoral)Access via the femoral artery; may be appropriate for patients with hostile neck anatomy or who cannot undergo general anesthesia.
    Selection principleChoice between TCAR and TF-CAS depends on individual clinical scenario and anatomic considerations.
    MO.MA Ultra Proximal Cerebral Protection Device
    Device nameMO.MA Ultra Proximal Cerebral Protection Device (Invatec S.p.A.)
    FDA identifierK092177
    Device typeProximal cerebral protection / embolic protection device used during carotid interventions.
    FilterWire EZ Embolic Protection System
    Device nameFilterWire EZ Embolic Protection System (Boston Scientific)
    FDA identifierK063313
    Size range notedReferenced as 3.5–5.5 mm in regulatory listings.
    ANGIOGUARD XP / ANGIOGUARD RX — device & clearances
    Device namesANGIOGUARD XP / ANGIOGUARD RX (Cordis)
    FDA identifiersK220654, K101651 (and K062531 listed as NTE)
    Device typeEmboli capture guidewire / embolic protection guidewire used during carotid stenting.
    Embolic Protection Device / Capture Guidewire — definition & examples
    DefinitionEmbolic protection devices and capture guidewires are adjunctive devices used during carotid stenting to capture or prevent emboli.
    ExamplesFilterWire EZ, ANGIOGUARD XP/RX, SPIDERFX, Emboshield NAV6, ACCUNET; capture guidewires (e.g., Cordis ANGIOGUARD RX).
    Regulatory noteMultiple FDA 510(k) K-numbers are listed for these devices in the regulatory section.
    Emboshield NAV6 — device and 510(k) clearances
    Device nameEmboshield NAV6 Embolic Protection System (Abbott Laboratories)
    Representative K-numbersK191173, K141678, K121015, K110909, K090665 (listed across regulatory entries)
    IncludesBareWire filter delivery wire noted among related clearances.
    SPIDERFX Embolic Protection Device — 510(k) listings
    Device nameSPIDERFX Embolic Protection Device (Ev3 / Medtronic listings)
    Representative K-numbersK111010, K063204, K052659 (listed in regulatory section)
    Regulatory datesClearance dates shown in entries (examples: 10/27/2011, 11/14/2006, 02/17/2006).
    ANGIOGUARD XP / ANGIOGUARD RX — definitions (repeat)
    Device namesANGIOGUARD XP / ANGIOGUARD RX (Cordis)
    FDA identifiersK220654, K101651, K062531 (NTE) listed across regulatory entries
    FunctionEmboli capture guidewire/device used as adjunct during carotid stenting procedures.
    ACCUNET Embolic Protection System / RX ACCUNET
    Device nameACCUNET Embolic Protection System / RX ACCUNET (Guidant/related listings)
    Representative K-numbersK153086, K081549, K052165, K042908, K042218 (appearing in regulatory section)
    NotesMultiple clearance dates and K-numbers are listed across regulatory entries.
    Emboshield NAV6 — definition
    Device nameEmboshield NAV6 Embolic Protection System (including BareWire delivery wire)
    Representative K-numbersK191173, K141678, K121015, K110909, K090665, K081523, K052454 (listed)
    ManufacturerAbbott Laboratories (listed in regulatory entries)
    SPIDERFX — definition
    Device nameSPIDERFX Embolic Protection Device
    Representative K-numbersK111010, K063204, K052659 (listed across entries)
    FunctionFilter-based embolic protection device used during carotid interventions.
    ACCUNET — definition
    Device nameACCUNET Embolic Protection System
    Representative K-numbersK153086, K081549, K052165, K042908, K042218 (listed in regulatory section)
    UseEmbolic protection system / filter device for carotid interventions.
    Capture Guidewire / ANGIOGUARD — definition
    Device typeCapture guidewire — emboli capture guidewire used during carotid stenting (e.g., ANGIOGUARD RX).
    ExampleANGIOGUARD RX Emboli Capture Guidewire (Cordis) with K220654, K101651, K062531 referenced.
    PurposeDesigned to capture embolic debris during carotid stenting to reduce cerebral embolization.
    ACCUNET Embolic Protection System — repeated entry
    Device nameACCUNET Embolic Protection System (repeated listings)
    K-numbers repeatedK153086, K081549, K052165, K042908 appear across multiple entries and dates.
    Regulatory noteMultiple clearance dates and related K-numbers are documented in the regulatory section.
    Emboshield NAV6 — repeated entry with clearances
    Device nameEmboshield NAV6 Embolic Protection System (repeated listings)
    K-numbers repeatedK191173, K141678, K121015, K110909, K090665, K081523, K052454 listed across entries.
    Regulatory noteClearance dates range across 2005–2019 in the regulatory listings.
    Embolic Protection Systems — example listings with multiple K-numbers
    Device examplesSPIDERFX, Emboshield NAV6, ACCUNET, ANGIOGUARD (capture guidewire)
    K-numbers (examples)K111010, K063204, K052659, K191173, K153086, K220654 (among many others listed)
    Regulatory contextMultiple FDA 510(k) clearances and dates are listed for these embolic protection systems across the regulatory section.
    InterQual® — definition and role in this policy
    Proprietary criteriaInterQual® — proprietary clinical decision support criteria referenced by Priority Health to determine medical necessity for the referenced procedures.
    Use in policyMedical necessity determinations for carotid artery stenting and intracranial angioplasty/stenting are governed by the applicable InterQual criteria.
    DocumentationProviders must document that InterQual criteria are met when claiming medical necessity per the policy guidance.